From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).

Susanne Deininger* (First author), Peter Törzsök (Co-author), Michael Mitterberger (Co-author), Maximilian Pallauf (Co-author), David Oswald (Co-author), Christian Deininger (Co-author), Lukas Lusuardi (Last author)

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Citations (Web of Science)
Original languageEnglish
JournalCancers
Volume14
Issue number3
DOIs
Publication statusPublished - 2022

Keywords

  • TUMOR-INFILTRATING LYMPHOCYTES
  • CARCINOMA IN-SITU
  • METASTATIC UROTHELIAL CARCINOMA
  • PHASE-II
  • SINGLE-ARM
  • HIGH-GRADE
  • OPEN-LABEL
  • RADICAL CYSTECTOMY
  • VACCINE
  • RISK

Cite this